23
Participants
Start Date
December 31, 2025
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2027
Digoxin
2.5-10 mcg/kg/day orally divided twice daily or once daily based on age on a continuous dosing schedule.
RECRUITING
Montefiore Medical Center, The Bronx
NOT_YET_RECRUITING
Children's National Medical Center, Washington D.C.
NOT_YET_RECRUITING
Johns Hopkins University, Baltimore
NOT_YET_RECRUITING
University of North Carolina, Chapel Hill
RECRUITING
Levine Cancer Institute, Charlotte
NOT_YET_RECRUITING
Nemours Jacksonville, Jacksonville
NOT_YET_RECRUITING
University of Miami, Miami
NOT_YET_RECRUITING
St. Joseph's Children's Hospital, Tampa
NOT_YET_RECRUITING
Johns Hopkins All Children's, St. Petersburg
RECRUITING
University of Alabama at Birmingham Children's of Alabama, Birmingham
NOT_YET_RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
Washington University St. Louis, St Louis
NOT_YET_RECRUITING
UT Southwestern, Dallas
NOT_YET_RECRUITING
Connecticut Children's Medical Center, Hartford
National Pediatric Cancer Foundation
OTHER
H. Lee Moffitt Cancer Center and Research Institute
OTHER